188 related articles for article (PubMed ID: 35331259)
1. Targeted-detection and sequential-treatment of small hepatocellular carcinoma in the complex liver environment by GPC-3-targeted nanoparticles.
Deng H; Shang W; Wang K; Guo K; Liu Y; Tian J; Fang C
J Nanobiotechnology; 2022 Mar; 20(1):156. PubMed ID: 35331259
[TBL] [Abstract][Full Text] [Related]
2. Enhanced glypican-3-targeted identification of hepatocellular carcinoma with liver fibrosis by pre-degrading excess fibrotic collagen.
Zhuo J; Wang Y; Hui H; Li C; Yang J; Zhang P; Fang C; Tian J
Acta Biomater; 2023 Mar; 158():435-448. PubMed ID: 36603729
[TBL] [Abstract][Full Text] [Related]
3. Targeted and Multifunctional Technology for Identification between Hepatocellular Carcinoma and Liver Cirrhosis.
Deng H; Shang W; Lu G; Guo P; Ai T; Fang C; Tian J
ACS Appl Mater Interfaces; 2019 Apr; 11(16):14526-14537. PubMed ID: 30776888
[TBL] [Abstract][Full Text] [Related]
4. Development and
Ma XH; Wang S; Liu SY; Chen K; Wu ZY; Li DF; Mi YT; Hu LB; Chen ZW; Zhao XM
World J Gastroenterol; 2019 Jun; 25(24):3030-3043. PubMed ID: 31293339
[TBL] [Abstract][Full Text] [Related]
5. A multifunctional targeted nanoprobe with high NIR-II PAI/MRI performance for precise theranostics of orthotopic early-stage hepatocellular carcinoma.
He L; Zhang Y; Chen J; Liu G; Zhu J; Li X; Li D; Yang Y; Lee CS; Shi J; Yin C; Lai P; Wang L; Fang C
J Mater Chem B; 2021 Nov; 9(42):8779-8792. PubMed ID: 34635903
[TBL] [Abstract][Full Text] [Related]
6. Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules.
Terzi E; Iavarone M; Pompili M; Veronese L; Cabibbo G; Fraquelli M; Riccardi L; De Bonis L; Sangiovanni A; Leoni S; Zocco MA; Rossi S; Alessi N; Wilson SR; Piscaglia F;
J Hepatol; 2018 Mar; 68(3):485-492. PubMed ID: 29133247
[TBL] [Abstract][Full Text] [Related]
7. Liver transplantation in cirrhotic patients with small hepatocellular carcinoma: an analysis of pre-operative imaging, explant histology and prognostic histologic indicators.
Bhattacharjya S; Bhattacharjya T; Quaglia A; Dhillon AP; Burroughs AK; Patch DW; Tibballs JM; Watkinson AF; Rolles K; Davidson BR
Dig Surg; 2004; 21(2):152-9; discussion 159-60. PubMed ID: 15166485
[TBL] [Abstract][Full Text] [Related]
8. Characterization of primary and recurrent nodules in liver cirrhosis using contrast-enhanced ultrasound: which vascular criteria should be adopted?
Leoni S; Piscaglia F; Granito A; Borghi A; Galassi M; Marinelli S; Terzi E; Bolondi L
Ultraschall Med; 2013 Jun; 34(3):280-7. PubMed ID: 23616066
[TBL] [Abstract][Full Text] [Related]
9. Targeted MR Imaging Adopting T1-Weighted Ultra-Small Iron Oxide Nanoparticles for Early Hepatocellular Carcinoma: An
Xu YH; Yang J; Meng J; Wang H
Chin Med Sci J; 2020 Jun; 35(2):142-150. PubMed ID: 32684234
[TBL] [Abstract][Full Text] [Related]
10. Detection of hepatocellular carcinoma in transgenic mice by Gd-DTPA- and rhodamine 123-conjugated human serum albumin nanoparticles in T1 magnetic resonance imaging.
Watcharin W; Schmithals C; Pleli T; Köberle V; Korkusuz H; Hübner F; Waidmann O; Zeuzem S; Korf HW; Terfort A; Gelperina S; Vogl TJ; Kreuter J; Piiper A
J Control Release; 2015 Feb; 199():63-71. PubMed ID: 25499552
[TBL] [Abstract][Full Text] [Related]
11. Cell-penetrating Peptide-modified Targeted Drug-loaded Phase-transformation Lipid Nanoparticles Combined with Low-intensity Focused Ultrasound for Precision Theranostics against Hepatocellular Carcinoma.
Zhao H; Wu M; Zhu L; Tian Y; Wu M; Li Y; Deng L; Jiang W; Shen W; Wang Z; Mei Z; Li P; Ran H; Zhou Z; Ren J
Theranostics; 2018; 8(7):1892-1910. PubMed ID: 29556363
[No Abstract] [Full Text] [Related]
12. Prospective evaluation of gadoxetic acid magnetic resonance for the diagnosis of hepatocellular carcinoma in newly detected nodules ≤2 cm in cirrhosis.
Ayuso C; Forner A; Darnell A; Rimola J; García-Criado Á; Bianchi L; Vilana R; Oliveira R; Llarch N; Bruix J
Liver Int; 2019 Jul; 39(7):1281-1291. PubMed ID: 31077539
[TBL] [Abstract][Full Text] [Related]
13. Radiomics machine-learning signature for diagnosis of hepatocellular carcinoma in cirrhotic patients with indeterminate liver nodules.
Mokrane FZ; Lu L; Vavasseur A; Otal P; Peron JM; Luk L; Yang H; Ammari S; Saenger Y; Rousseau H; Zhao B; Schwartz LH; Dercle L
Eur Radiol; 2020 Jan; 30(1):558-570. PubMed ID: 31444598
[TBL] [Abstract][Full Text] [Related]
14. Evolution of indeterminate hepatocellular nodules at Gd-EOB-DPTA-enhanced MRI in cirrhotic patients.
Galia M; Agnello F; Sparacia G; Matranga D; Albano D; Midiri M; Lagalla R
Radiol Med; 2018 Jul; 123(7):489-497. PubMed ID: 29546493
[TBL] [Abstract][Full Text] [Related]
15. New Arterial Phase Enhancing Nodules on MRI of Cirrhotic Liver: Risk of Progression to Hepatocellular Carcinoma and Implications for LI-RADS Classification.
Smereka P; Doshi AM; Lavelle LP; Shanbhogue K
AJR Am J Roentgenol; 2020 Aug; 215(2):382-389. PubMed ID: 32432909
[No Abstract] [Full Text] [Related]
16. Contrast imaging techniques to diagnose hepatocellular carcinoma in cirrhotics outside regular surveillance.
Iavarone M; Viganò M; Piazza N; Occhipinti V; Sangiovanni A; Maggioni M; D'Ambrosio G; Forzenigo LV; Motta F; Lampertico P; Rumi MG; Colombo M
Ann Hepatol; 2019; 18(2):318-324. PubMed ID: 31036496
[TBL] [Abstract][Full Text] [Related]
17. Glypican-3 as a useful diagnostic marker that distinguishes hepatocellular carcinoma from benign hepatocellular mass lesions.
Wang HL; Anatelli F; Zhai QJ; Adley B; Chuang ST; Yang XJ
Arch Pathol Lab Med; 2008 Nov; 132(11):1723-8. PubMed ID: 18976006
[TBL] [Abstract][Full Text] [Related]
18. CEUS: An essential component in a multimodality approach to small nodules in patients at high-risk for hepatocellular carcinoma.
Jang HJ; Kim TK; Burns PN; Wilson SR
Eur J Radiol; 2015 Sep; 84(9):1623-35. PubMed ID: 26092406
[TBL] [Abstract][Full Text] [Related]
19. Rate of hepatocellular carcinoma diagnosis in cirrhotic patients with ultrasound-detected liver nodules.
Franzè MS; Bottari A; Caloggero S; Pitrone A; Barbera A; Lembo T; Caccamo G; Cacciola I; Maimone S; Alibrandi A; Pitrone C; Squadrito G; Raimondo G; Saitta C
Intern Emerg Med; 2021 Jun; 16(4):949-955. PubMed ID: 33111165
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic Accuracy of CEUS LI-RADS for the Characterization of Liver Nodules 20 mm or Smaller in Patients at Risk for Hepatocellular Carcinoma.
Huang JY; Li JW; Lu Q; Luo Y; Lin L; Shi YJ; Li T; Liu JB; Lyshchik A
Radiology; 2020 Feb; 294(2):329-339. PubMed ID: 31793849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
